We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

79 hedge funds and large institutions have $17.6M invested in Acorda Therapeutics in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 27 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% less funds holding

Funds holding: 106 → 79 (-27)

48% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 27

56% less capital invested

Capital invested by funds: $39.9M → $17.6M (-$22.3M)

60% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 45

96% less call options, than puts

Call options by funds: $101K | Put options by funds: $2.41M

Holders
79
Holders Change
-27
Holders Change %
-25.47%
% of All Funds
1.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
14
Reduced
27
Closed
45
Calls
$101K
Puts
$2.41M
Net Calls
-$2.31M
Net Calls Change
+$1.38M

Top Buyers

1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$515K
2
Millennium Management
Millennium Management
New York
+$400K
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$249K
4
Jane Street
Jane Street
New York
+$229K
5
PP
Paloma Partners
Connecticut
+$210K

Top Sellers

1
BlackRock
BlackRock
New York
-$5.44M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.02M
3
PHS
PFM Health Sciences
California
-$1.42M
4
State Street
State Street
Massachusetts
-$1.28M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$777K
Name Holding Trade Value Shares
Change 		Change in
Stake
Squarepoint
26
Squarepoint
New York
$97K +$116K +1,102 New
SEI Investments
27
SEI Investments
Pennsylvania
$92K – – –
BNP Paribas Financial Markets
28
BNP Paribas Financial Markets
France
$89.9K +$90.8K +859 +534%
Wells Fargo
29
Wells Fargo
California
$81K -$10.8K -102 -10%
QI
30
QS Investors
New York
$73K – – –
Russell Investments Group
31
Russell Investments Group
United Kingdom
$71K +$38.8K +367 +83%
Group One Trading
32
Group One Trading
Illinois
$64K +$77.3K +731 New
UBS Group
33
UBS Group
Switzerland
$51K +$6.13K +58 +11%
Bank of America
34
Bank of America
North Carolina
$51K +$49.3K +466 +405%
Qube Research & Technologies (QRT)
35
Qube Research & Technologies (QRT)
United Kingdom
$42K +$50.3K +476 New
GCP
36
GSA Capital Partners
United Kingdom
$40K -$173K -1,636 -78%
Capstone Investment Advisors
37
Capstone Investment Advisors
New York
$39K – – –
William Blair & Company
38
William Blair & Company
Illinois
$39K +$47.4K +448 New
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$37K – – –
State Street
40
State Street
Massachusetts
$27K -$1.28M -12,139 -98%
Morgan Stanley
41
Morgan Stanley
New York
$25K -$174K -1,645 -85%
PPA
42
Parametric Portfolio Associates
Washington
$23K -$33.1K -313 -55%
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$21K -$3.81K -36 -13%
SG Americas Securities
44
SG Americas Securities
New York
$20K +$8.88K +84 +58%
VF
45
Virtu Financial
New York
$20K +$23.7K +224 New
ARTA
46
A.R.T. Advisors
New York
$20K +$24.3K +230 New
Bank of New York Mellon
47
Bank of New York Mellon
New York
$19K -$444K -4,201 -95%
SM
48
Salzhauer Michael
$19K -$3.17K -30 -12%
WS
49
Wedbush Securities
California
$18K -$1.06K -10 -5%
SBIA
50
Sheaff Brock Investment Advisors
Indiana
$18K +$22K +208 New
1
2
3 4 5

ACOR Hedge Fund Activity: Q2 2020 in Review

79 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q2 2020, worth a combined $17.6M — down 56% from $39.9M a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of ACOR and 18 opened new positions — a net loss of 27 holders — while 27 trimmed existing stakes and 14 added.

The largest buyer was Arrowstreet Capital, opening a new position worth an estimated $515K. The largest seller was BlackRock, cutting an estimated $5.44M.

  • 79 institutional investors held Acorda Therapeutics (ACOR) as of Q2 2020, down from 106 in Q1 2020.
  • Funds reported $17.6M of Acorda Therapeutics stock for Q2 2020, down 56% quarter-over-quarter.
  • 18 funds opened new Acorda Therapeutics positions in Q2 2020 and 45 closed out, a net change of -27 holders.
  • The largest Acorda Therapeutics buyer in Q2 2020 was Arrowstreet Capital, an estimated $515K added.
  • The largest Acorda Therapeutics seller in Q2 2020 was BlackRock, an estimated $5.44M sold.

Based on aggregated 13F filings for Q2 2020.